Pharma Industry Infonugget #5 - How often did companies review their CMO contracts?
|
Pharma Industry Infonugget 5
How often did companies review their CMO contracts?
To see if this trend has continued please visit PharmaIQ
55.6% review contracts every 6 months
33.3% say they review their contracts annually
11.1% leave contracts in place for 2-3 years without review
For other statistics and further pharma business trends, attend our conferences.
About Pharma Industry
This page is part of our content series that focuses on Pharma IQ's free online resources for the pharma industry.
-
Drug Discovery Partnerships - Challenges and Opportunities -
Drugs in Sport: How should the Pharma Industry Respond? -
6 Hot Topics for Disposable Solutions in Biomanufacturing -
Clinical Research “Likely to Return to the UK” Following Change in Patent Law -
High-Throughput Screening: Best Practice, Trends and Challenges -
Pharma Industry Infonugget #5 - How often did companies review their CMO contracts? -
The Top 10 Pinnacle Moments in the Pharma Industry -
"Haven’t We Changed Enough?": Overcoming Barriers to Continuous Improvement -
3 Reasons Process Excellence Matters to Pharmaceutical Companies -
Pharma Industry Infonugget #4 - How do businesses find CMOs?
* = required.
Not a member yet? Sign up
You Should Check Out:





Not a member? Sign Up
Reasons for Joining
Address your challenges through knowledge sharing with peers from our global network of specialists.
Benchmark your business initiatives with the who's who in the field.
Hear from industry pioneers how to maximize ROI in today's challenging economy.
And best of all It's FREE!